What is its status?
Read what the selected regulatory and other official records support, and when those sources were checked.
Find cited status →Public beta · Selective source coverage
Peptide records.
Without the hype.
Find a peptide’s research, trial registrations, and regulatory records. Read an evidence review or open the original sources.
Explore 2,747 cited source records. Browse the archive → · Sources and coverage →
Start with your question
Find the evidence that matters to your question.
Choose a peptide, then go straight to its cited status, reviewed human evidence, or collection history. Each answer keeps its sources, dates, and uncertainty visible.
What do human studies say?
Explore human evidence reviews and the publications and trial records behind each profile.
Explore human evidence →What changed in the collection?
Separate newly added records, revised conclusions, and corrections. A new addition is not automatically a new finding.
Inspect collection history →Working across the evidence? Open the research atlas, browse Human Evidence Reviews, or inspect the FDA compounding tracker.
Fresh from the sources
Latest peptide research
Clinical trials · Semaglutide
ClinicalTrials.gov record NCT03811561
PeptideScanner retained ClinicalTrials.gov record NCT03811561 at 2026-09-09T19:17:17.089Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.
Source: ClinicalTrials.gov ↗
Clinical trials · Petrelintide
ClinicalTrials.gov record NCT06926842
PeptideScanner retained ClinicalTrials.gov record NCT06926842 at 2026-09-09T19:17:17.080Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was petrelintide.
Source: ClinicalTrials.gov ↗
Clinical trials · Tirzepatide
ClinicalTrials.gov record NCT07247084
PeptideScanner retained ClinicalTrials.gov record NCT07247084 at 2026-09-09T19:17:17.101Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was tirzepatide.
Source: ClinicalTrials.gov ↗
Clinical trials · Semaglutide
ClinicalTrials.gov record NCT07662213
PeptideScanner retained ClinicalTrials.gov record NCT07662213 at 2026-09-09T19:17:17.121Z. Its registry update date was 2026-09-09, and PeptideScanner's reviewed identity mapping was semaglutide.
Source: ClinicalTrials.gov ↗
Literature metadata · Semaglutide
"I Believe in Santa Claus" and Ozempic: A Foucauldian Discourse Analysis of Holiday Health Advertising.
PubMed lists PMID 40536021 in Qualitative health research as Journal Article, with publication-date metadata of 2025-06-19 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
Source: PubMed ↗
Citable by design
Take the sources with you.
Every story has a versioned evidence object with source pins and correction history. Build an evidence pack, open the agent navigation index, or check coverage and gaps.
Our standard
“Report what the source says—then show the source.”
PeptideScanner separates regulatory records, trial registrations, and company or institutional statements from established scientific truth. If something is unclear, we label the uncertainty or leave it unpublished.
Read our methodology